Navigation Links
Robbins & Myers Presenting at Bear Stearns 3rd Annual Commodities and Capital Goods Conference November 28, 2007
Date:11/16/2007

DAYTON, Ohio, Nov. 16 /PRNewswire-FirstCall/ -- Robbins & Myers, Inc. (NYSE: RBN) announced today that it will participate at the Bear Stearns 3rd Annual Commodities and Capital Goods Conference in New York City on November 28, 2007. Peter C. Wallace, President and Chief Executive Officer and Christopher M. Hix, Vice President and Chief Financial Officer, will be presenting for the Company.

The Company's presentation is set for 2:00-2:25 p.m., EST, on Wednesday, November 28th at Bear Stearns World Headquarters, 383 Madison Avenue at 47th Street, New York, NY. The presentation will be webcast live and available through the Company's website at http://www.robn.com . It will be posted to the "Investor Relations" section and accessible for 30 days.

Robbins & Myers, Inc. is a leading global supplier of highly-engineered, application-critical equipment and systems to the global energy, chemical, pharmaceutical and industrial markets.


'/>"/>
SOURCE Robbins & Myers, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Robbins & Myers to Release Fourth Quarter and 2007 Fiscal Year Results on Monday, October 15, 2007
2. Robbins & Myers Announces Regular Quarterly Cash Dividend
3. Robbins Bros. Gives Water at AIDS Walk L.A.
4. Bristol-Myers Squibb Announces Dividend
5. Jeremy Levin Joins Bristol-Myers Squibb as Senior Vice President of External Science, Technology and Licensing
6. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
7. Bristol-Myers Squibb to Announce Results for the Third Quarter of 2007 on October 25
8. Pharmacopeia Acquires Selective Androgen Receptor Modulator (SARM) Program from Bristol-Myers Squibb
9. ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan
10. American Cancer Society to Present Highest Honor to Matthew L. Myers, Douglas R. Lowy, and Mark Schiffman for Outstanding Contributions to Cancer Fight
11. eHealth Initiative Releases Blueprint Representing Consensus on an Action Plan for Transforming U.S. Healthcare Using Health IT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... 2017 , ... Forty-five percent of American respondents feel that ... or friends have also commented about their poor hearing. However, only 13 percent ... reason, suggested by 89 percent of American respondents, is that they don’t want ...
(Date:2/22/2017)... ... , ... Social media marketing is transitioning from a singular person activity to ... delves into this insight and more in its latest episode of its Brains Over ... up with social media strategist and partner of the digital firm Med|Ed Digital Jessica ...
(Date:2/22/2017)... ... February 22, 2017 , ... In a recent ... the patient context (age, illness and life choices) should be dissociated from medical ... In addition, all too often, studies regarding health system performance in ...
(Date:2/21/2017)... ... February 22, 2017 , ... Author Michèle Wolff has a passion for using ... family to know all about it for optimal health. Wanting to share her knowledge ... Detox, Digestive and Wellness Solutions ” (published by Balboa Press AU). , This ...
(Date:2/21/2017)... , ... February 21, 2017 , ... Doctors on Liens ... directed by Dr. Kendell Mendonca , to its growing network of doctors in ... including injuries stemming from car accidents such as whiplash, back pain, neck pain, hip ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... 22, 2017  Bioness, Inc., the leading provider of ... first series of successful StimRouter Neuromodulation System implantations in ... Center (Nijmegen, Netherlands ), ... ), and Kliniek Park Leopold Chirec ( ... Bioness plans to further support clinicians across the continent ...
(Date:2/22/2017)... PUNE, India , February 22, 2017 According ... (Spectroscopy, Chromatography), Measurement (On-Line, In-Line, At-Line), Products and Services (Analyzers, Probes & ... to 2021", published by MarketsandMarkets, the global market is poised to reach ... a CAGR of 13.3% from 2016 to 2021. ... ...
(Date:2/22/2017)... SEATTLE , Feb. 22, 2017 ... translational development of novel immune modulating therapies, today ... the a9a10 nicotinic acetylcholine receptor (nAChR), demonstrates robust ... preclinical pain models. The study also establishes the ... the treatment of chronic pain. The findings were ...
Breaking Medicine Technology: